(E)-1-benzyl-4(2-((3,4-dimethoxyphenyl)sulfonyl)vinyl)piperidine

ID: ALA5209880

PubChem CID: 168297974

Max Phase: Preclinical

Molecular Formula: C22H27NO4S

Molecular Weight: 401.53

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(S(=O)(=O)/C=C/C2CCN(Cc3ccccc3)CC2)cc1OC

Standard InChI:  InChI=1S/C22H27NO4S/c1-26-21-9-8-20(16-22(21)27-2)28(24,25)15-12-18-10-13-23(14-11-18)17-19-6-4-3-5-7-19/h3-9,12,15-16,18H,10-11,13-14,17H2,1-2H3/b15-12+

Standard InChI Key:  BFMSOQNGIADECS-NTCAYCPXSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
  -12.6043    2.1181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.3187    1.7055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.3187    0.8805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.6042    0.4681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.8897    0.8806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.8898    1.7056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1752    0.4682    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4607    0.0557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7463    0.4682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0318    0.0558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3174    0.4683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6029    0.0559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6028   -0.7691    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3173   -1.1817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0318   -0.7692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8883   -1.1816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8883   -2.0066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1738   -2.4190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1737   -3.2440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8882   -3.6566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6027   -3.2441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6027   -2.4191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.5877   -0.2463    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7628    1.1826    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -14.0332    2.1180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -14.0333    2.9430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.6043    2.9431    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.8899    3.3556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  1  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 11 10  1  0
 12 11  1  0
 13 12  1  0
 14 13  1  0
 15 14  1  0
 10 15  1  0
 13 16  1  0
 16 17  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 17 22  1  0
  7 23  2  0
  7 24  2  0
  2 25  1  0
 25 26  1  0
  1 27  1  0
 27 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5209880

    ---

Associated Targets(non-human)

Ache Acetylcholinesterase (1323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 401.53Molecular Weight (Monoisotopic): 401.1661AlogP: 3.90#Rotatable Bonds: 7
Polar Surface Area: 55.84Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.33CX LogP: 3.32CX LogD: 3.05
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.70Np Likeness Score: -0.63

References

1. Liu Y, Uras G, Onuwaje I, Li W, Yao H, Xu S, Li X, Li X, Phillips J, Allen S, Gong Q, Zhang H, Zhu Z, Liu J, Xu J..  (2022)  Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease.,  235  [PMID:35339839] [10.1016/j.ejmech.2022.114305]

Source